VIRIDIAN Trademark

Trademark Overview

On Tuesday, June 23, 2009, a trademark application was filed for VIRIDIAN with the United States Patent and Trademark Office. The USPTO has given the VIRIDIAN trademark a serial number of 77766321. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 14, 2023. This trademark is owned by Viridian Strategies, LLC. The VIRIDIAN trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing business consulting services to drug companies and biotechnology companies to aid in the management of clinical trials, namely, the implementation of clinical trials, the management of vendors involved in clinical trials, and the resolution of issues arising in clinical development programs; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies...
viridian

General Information

Serial Number77766321
Word MarkVIRIDIAN
Filing DateTuesday, June 23, 2009
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 14, 2023
Registration Number4175944
Registration DateTuesday, July 17, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2010

Trademark Statements

Goods and ServicesProviding business consulting services to drug companies and biotechnology companies to aid in the management of clinical trials, namely, the implementation of clinical trials, the management of vendors involved in clinical trials, and the resolution of issues arising in clinical development programs; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, June 26, 2009
Primary Code035
First Use Anywhere DateTuesday, June 30, 2009
First Use In Commerce DateTuesday, June 30, 2009

Trademark Owner History

Party NameViridian Strategies, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBarnstable, MA 02630
Party NameViridian Strategies, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAndover, MA 01810
Party NameViridian Strategies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAndover, MA 01810

Trademark Events

Event DateEvent Description
Tuesday, March 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, March 14, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 14, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 26, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, July 17, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, December 3, 2018SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Monday, December 3, 2018REGISTERED - SEC. 15 ACKNOWLEDGED
Wednesday, November 28, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 30, 2018TEAS SECTION 15 RECEIVED
Saturday, July 21, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, July 21, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Saturday, July 21, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 14, 2018TEAS SECTION 8 RECEIVED
Saturday, July 14, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 17, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, June 13, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 12, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, June 7, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2012STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 1, 2012USE AMENDMENT FILED
Tuesday, June 5, 2012SOU EXTENSION 3 GRANTED
Tuesday, May 1, 2012SOU EXTENSION 3 FILED
Tuesday, May 1, 2012TEAS EXTENSION RECEIVED
Tuesday, May 1, 2012TEAS STATEMENT OF USE RECEIVED
Wednesday, November 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 1, 2011SOU EXTENSION 2 GRANTED
Saturday, October 29, 2011SOU EXTENSION 2 FILED
Saturday, October 29, 2011TEAS EXTENSION RECEIVED
Thursday, April 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2011SOU EXTENSION 1 GRANTED
Friday, April 15, 2011SOU EXTENSION 1 FILED
Wednesday, April 20, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 15, 2011TEAS EXTENSION RECEIVED
Tuesday, November 2, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 7, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2010PUBLISHED FOR OPPOSITION
Saturday, July 31, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, July 31, 2010ASSIGNED TO LIE
Monday, July 19, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2010NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 14, 2010FINAL REFUSAL E-MAILED
Wednesday, April 14, 2010FINAL REFUSAL WRITTEN
Wednesday, March 24, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 23, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 23, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 25, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 25, 2009NON-FINAL ACTION E-MAILED
Friday, September 25, 2009NON-FINAL ACTION WRITTEN
Monday, September 21, 2009ASSIGNED TO EXAMINER
Friday, June 26, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2009NEW APPLICATION ENTERED

Related Keywords

viridian clinical management trials regulatory companies namely business biotechnology consulting providing